Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 04, 2021 09:55 ET | Source: GeoVax, Inc.

GeoVax Expands and Strengthens Intellectual Property Portfolio

Filings Made in Corporate Focus Areas of SARS-CoV-2 and Immuno-Oncology Atlanta, GA, March 04, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX) (“GeoVax” or the...
March 03, 2021 09:00 ET | Source: GeoVax, Inc.

GeoVax to Present at the H.C. Wainwright Global Life Sciences Conference

Virtual Conference to be Held March 9-10, 2021 ATLANTA, GA, March 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX), a biotechnology company developing vaccines...
March 01, 2021 09:00 ET | Source: GeoVax, Inc.

Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring GeoVax’s CEO & CFO On March 3, 2021

Meet with GeoVax CEO David Dodd & CFO Mark Reynolds who will Deliver a Presentation Titled “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” ATLANTA,...
February 11, 2021 14:00 ET | Source: GeoVax, Inc.

GeoVax Announces Closing of $10.3 Million Bought Deal Offering

Atlanta, GA, Feb. 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and...
February 08, 2021 23:43 ET | Source: GeoVax, Inc.

GeoVax Announces Pricing of $9.0 Million Bought Deal Offering

ATLANTA, GA, Feb. 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (Nasdaq: GOVX) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and vaccines...
January 11, 2021 09:00 ET | Source: GeoVax, Inc.

GeoVax Awarded NIH Grant to Advance COVID-19 Vaccine Development

Company Focused on Single-dose Vaccine Against Multiple COVID Strains ATLANTA, GA, Jan. 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX), a biotechnology company...
January 05, 2021 09:00 ET | Source: GeoVax, Inc.

GeoVax to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference

GeoVax Also Participating in BIO@JPM During “J.P. Morgan Week 2021” ATLANTA, GA, Jan. 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX), a biotechnology company...
November 30, 2020 09:00 ET | Source: GeoVax, Inc.

GeoVax Announces License Agreement With NIH to Support Continued Advancements in Vaccine Development

Atlanta, GA, Nov. 30, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX, GOVXW) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies...
November 05, 2020 17:00 ET | Source: GeoVax, Inc.

GeoVax Reports 2020 Third Quarter Financial Results and Provides Corporate Update

Public Offering Completed in September 2020 Provides Resources to Accelerate COVID-19 Vaccine and Immuno-Oncology Programs ATLANTA, GA, Nov. 05, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire --...
October 30, 2020 10:08 ET | Source: GeoVax, Inc.

GeoVax to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update

Conference call to be held Friday, November 6, at 8:15 a.m. Eastern Time ATLANTA, GA, Oct. 30, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX, GOVXW) (“GeoVax”...